Literature DB >> 25231591

[Exanthems and fever in travellers returning from the tropics].

M Fischer1, S Schliemann.   

Abstract

Dengue fever with its subtle rash is today more common than malaria in travellers returning to Europe from the tropics (meta-analysis Geo Sentinel network). Up to 5 % of all safari tourists experience African tick bite fever during or soon after their journey; it is caused by rickettsiae and clinically presents with exanthems, focal necrotizing vasculitis (eschar, tache noir), lymphadenopathy and moderate fever. Typhoid fever is a severe infectious disease is which is difficult to diagnosis at first assessment. The presence of rose spots, which may be found in up to 33 % of patients with typhoid fever, can lead the way to diagnosis. Exanthems can be subtle and may occur weeks after infection without any other distinctive clinical sign. Particular importance in travel medicine has to be paid to acute HIV infection and secondary syphilis after exposition and infection in the tropics. Also the highly contagious infectious diseases of childhood as measles and rubeola have to be taken into account in adults with no or insufficient vaccination after a stay in tropical countries.

Entities:  

Mesh:

Year:  2014        PMID: 25231591     DOI: 10.1007/s00105-014-3507-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  11 in total

1.  Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa.

Authors:  D Raoult; P E Fournier; F Fenollar; M Jensenius; T Prioe; J J de Pina; G Caruso; N Jones; H Laferl; J E Rosenblatt; T J Marrie
Journal:  N Engl J Med       Date:  2001-05-17       Impact factor: 91.245

2.  [Vacation and tropical dermatoses].

Authors:  M Fischer; D Reinel
Journal:  Hautarzt       Date:  2012-05       Impact factor: 0.751

3.  Travellers returning with measles from Thailand to Finland, April 2012: infection control measures.

Authors:  A Kantele; K Valtonen; I Davidkin; T Martelius; N Võželevskaja; K Skogberg; I Liesmaa; O Lyytikäinen
Journal:  Euro Surveill       Date:  2012-05-31

4.  Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii.

Authors:  Juan J Martinez; Stéphanie Seveau; Esteban Veiga; Shigemi Matsuyama; Pascale Cossart
Journal:  Cell       Date:  2005-12-16       Impact factor: 41.582

5.  Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Authors:  Frederick M Hecht; Michael P Busch; Bhupat Rawal; Marcy Webb; Eric Rosenberg; Melinda Swanson; Margaret Chesney; Jennifer Anderson; Jay Levy; James O Kahn
Journal:  AIDS       Date:  2002-05-24       Impact factor: 4.177

6.  Management of travelers with fever and exanthema, notably dengue and chikungunya infections.

Authors:  Patrick Hochedez; Ana Canestri; Amélie Guihot; Ségolène Brichler; François Bricaire; Eric Caumes
Journal:  Am J Trop Med Hyg       Date:  2008-05       Impact factor: 2.345

Review 7.  The exanthem of dengue fever: Clinical features of two US tourists traveling abroad.

Authors:  Laura B Pincus; Marc E Grossman; Lindy P Fox
Journal:  J Am Acad Dermatol       Date:  2007-10-24       Impact factor: 11.527

Review 8.  Viruses acquired abroad: what does the primary care physician need to know?

Authors:  Jonas Schmidt-Chanasit; Stefan Schmiedel; Bernhard Fleischer; Gerd-Dieter Burchard
Journal:  Dtsch Arztebl Int       Date:  2012-10-12       Impact factor: 5.594

9.  Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008.

Authors:  Mogens Jensenius; Xiaohong Davis; Frank von Sonnenburg; Eli Schwartz; Jay S Keystone; Karin Leder; Rogelio Lopéz-Véléz; Eric Caumes; Jakob P Cramer; Lin Chen; Philippe Parola
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

10.  Early diagnosis of typhoid fever by nested PCR for flagellin gene of Salmonella enterica serotype Typhi.

Authors:  S Khan; B N Harish; G A Menezes; N S Acharya; S C Parija
Journal:  Indian J Med Res       Date:  2012-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.